Cargando…

Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey

OBJECTIVES: ‘Overdiagnosis’, detection of disease that would never have caused symptoms or death, is a public health concern due to possible psychological and physical harm but little is known about how best to explain it. This study evaluated public perceptions of widely used information on the con...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanouni, Alex, Renzi, Cristina, McBride, Emily, Waller, Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629687/
https://www.ncbi.nlm.nih.gov/pubmed/28827249
http://dx.doi.org/10.1136/bmjopen-2017-015955
_version_ 1783269094019039232
author Ghanouni, Alex
Renzi, Cristina
McBride, Emily
Waller, Jo
author_facet Ghanouni, Alex
Renzi, Cristina
McBride, Emily
Waller, Jo
author_sort Ghanouni, Alex
collection PubMed
description OBJECTIVES: ‘Overdiagnosis’, detection of disease that would never have caused symptoms or death, is a public health concern due to possible psychological and physical harm but little is known about how best to explain it. This study evaluated public perceptions of widely used information on the concept to identify scope for improving communication methods. DESIGN: Experimental survey carried out by a market research company via face-to-face computer-assisted interviews. SETTING: Interviews took place in participants’ homes. PARTICIPANTS: 2111 members of the general public in England aged 18–70 years began the survey; 1616 were eligible for analysis. National representativeness was sought via demographic quota sampling. INTERVENTIONS: Participants were allocated at random to receive a brief description of overdiagnosis derived from written information used by either the NHS Breast Screening Programme or the prostate cancer screening equivalent. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was how clear the information was perceived to be (extremely/very clear vs less clear). Other measures included previous exposure to screening information, decision-making styles and demographic characteristics (eg, education). Binary logistic regression was used to assess predictors of perceived clarity. RESULTS: Overdiagnosis information from the BSP was more likely to be rated as more clear compared with the prostate screening equivalent (adjusted OR: 1.43, 95% CI 1.17 to 1.75; p=0.001). Participants were more likely to perceive the information as more clear if they had previously encountered similar information (OR: 1.77, 1.40 to 2.23; p<0.0005) or a screening leaflet (OR: 1.35, 1.04 to 1.74; p=0.024) or had a more ‘rational’ decision-making style (OR: 1.06, 1.02 to 1.11; p=0.009). CONCLUSIONS: Overdiagnosis information from breast screening may be a useful template for communicating the concept more generally (eg, via organised campaigns). However, this information may be less well-suited to individuals who are less inclined to consider risks and benefits during decision-making.
format Online
Article
Text
id pubmed-5629687
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56296872017-10-11 Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey Ghanouni, Alex Renzi, Cristina McBride, Emily Waller, Jo BMJ Open Communication OBJECTIVES: ‘Overdiagnosis’, detection of disease that would never have caused symptoms or death, is a public health concern due to possible psychological and physical harm but little is known about how best to explain it. This study evaluated public perceptions of widely used information on the concept to identify scope for improving communication methods. DESIGN: Experimental survey carried out by a market research company via face-to-face computer-assisted interviews. SETTING: Interviews took place in participants’ homes. PARTICIPANTS: 2111 members of the general public in England aged 18–70 years began the survey; 1616 were eligible for analysis. National representativeness was sought via demographic quota sampling. INTERVENTIONS: Participants were allocated at random to receive a brief description of overdiagnosis derived from written information used by either the NHS Breast Screening Programme or the prostate cancer screening equivalent. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was how clear the information was perceived to be (extremely/very clear vs less clear). Other measures included previous exposure to screening information, decision-making styles and demographic characteristics (eg, education). Binary logistic regression was used to assess predictors of perceived clarity. RESULTS: Overdiagnosis information from the BSP was more likely to be rated as more clear compared with the prostate screening equivalent (adjusted OR: 1.43, 95% CI 1.17 to 1.75; p=0.001). Participants were more likely to perceive the information as more clear if they had previously encountered similar information (OR: 1.77, 1.40 to 2.23; p<0.0005) or a screening leaflet (OR: 1.35, 1.04 to 1.74; p=0.024) or had a more ‘rational’ decision-making style (OR: 1.06, 1.02 to 1.11; p=0.009). CONCLUSIONS: Overdiagnosis information from breast screening may be a useful template for communicating the concept more generally (eg, via organised campaigns). However, this information may be less well-suited to individuals who are less inclined to consider risks and benefits during decision-making. BMJ Publishing Group 2017-08-21 /pmc/articles/PMC5629687/ /pubmed/28827249 http://dx.doi.org/10.1136/bmjopen-2017-015955 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Communication
Ghanouni, Alex
Renzi, Cristina
McBride, Emily
Waller, Jo
Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey
title Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey
title_full Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey
title_fullStr Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey
title_full_unstemmed Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey
title_short Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey
title_sort comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in england: an experimental survey
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629687/
https://www.ncbi.nlm.nih.gov/pubmed/28827249
http://dx.doi.org/10.1136/bmjopen-2017-015955
work_keys_str_mv AT ghanounialex comparingperceivedclarityofinformationonoverdiagnosisusedforbreastandprostatecancerscreeninginenglandanexperimentalsurvey
AT renzicristina comparingperceivedclarityofinformationonoverdiagnosisusedforbreastandprostatecancerscreeninginenglandanexperimentalsurvey
AT mcbrideemily comparingperceivedclarityofinformationonoverdiagnosisusedforbreastandprostatecancerscreeninginenglandanexperimentalsurvey
AT wallerjo comparingperceivedclarityofinformationonoverdiagnosisusedforbreastandprostatecancerscreeninginenglandanexperimentalsurvey